NewsVandana Singh
Merck KGaA
MKGAF · XETRA
$167.21+$9.24 (+5.85%)TodayMarket closed ·
Prev close $157.97
Latest news
- NewsVandana Singh
Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal
- NewsVandana Singh
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
- NewsAvi Kapoor
Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday
- NewsVandana Singh
Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal
- NewsTanya Rawat
Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'
- NewsVandana Singh
Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
- NewsVandana Singh
Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
- NewsVandana Singh
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
- NewsEvette Mitkov
Invo Fertility Stock Is Plunging After White House Announcement
- NewsVandana Singh
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
- NewsVandana Singh
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
- NewsVandana Singh
Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
- NewsVandana Singh
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
- NewsVandana Singh
GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.